Physician profile
James Turner
NPI 1245424159
$6,318.89
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,502 · 2020: $1,527 · 2021: $2,194 · 2022: $95.88.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,155.95 | 2019-2021 | |
| Glaxosmithkline, LLC. | $913.54 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $768.29 | 2019-2020 | |
| Boston Scientific Corporation | $620.33 | 2019-2021 | |
| Mannkind Corporation | $525.69 | 2020-2021 | |
| Abbvie INC. | $379.79 | 2019-2020 | |
| Amarin Pharma, INC. | $274.95 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $269.33 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $261.52 | 2019 | |
| Novo Nordisk INC | $248.19 | 2021 | |
| Lilly USA, LLC | $148.92 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $133.33 | 2021 | |
| Novartis Pharmaceuticals Corporation | $124.83 | 2019 | |
| Abiomed | $100.00 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $88.07 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $86.35 | 2019-2020 | |
| Chiesi USA, INC. | $81.30 | 2022 | |
| Merck Sharp & Dohme LLC | $29.93 | 2019-2020 | |
| Amgen INC. | $29.34 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $27.50 | 2021 | |
| Nabriva Therapeutics, Plc | $13.99 | 2021 | |
| Pfizer INC. | $13.21 | 2020 | |
| Astellas Pharma US INC | $12.41 | 2019 | |
| Abbott Laboratories | $12.13 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.